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Abstract
GC-biased gene conversion (gBGC) is a recombination-associated process that favors the fixation of G/C
alleles over A/T alleles. In mammals, gBGC is hypothesized to contribute to variation in GC content, rapidly
evolving sequences, and the fixation of deleterious mutations, but its prevalence and general functional con-
sequences remain poorly understood. gBGC is difficult to incorporate into models of molecular evolution
and so far has primarily been studied using summary statistics from genomic comparisons. Here, we intro-
duce a new probabilistic model that captures the joint effects of natural selection and gBGC on nucleotide
substitution patterns, while allowing for correlations along the genome in these effects. We implemented
our model in a computer program, called phastBias, that can accurately detect gBGC tracts ∼1 kilobase or
longer in simulated sequence alignments. When applied to real primate genome sequences, phastBias pre-
dicts gBGC tracts that cover roughly 0.3% of the human and chimpanzee genomes and account for 1.2% of
human-chimpanzee nucleotide differences. These tracts fall in clusters, particularly in subtelomeric regions;
they are enriched for recombination hotspots and fast-evolving sequences; and they display an ongoing fix-
ation preference for G and C alleles. We also find some evidence that they contribute to the fixation of
deleterious alleles, including an enrichment for disease-associated polymorphisms. These tracts provide
a unique window into historical recombination processes along the human and chimpanzee lineages; they
supply additional evidence of long-term conservation of megabase-scale recombination rates accompanied
by rapid turnover of hotspots. Together, these findings shed new light on the evolutionary, functional, and
disease implications of gBGC. The phastBias program and our predicted tracts are freely available.
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Introduction
Gene conversion is the nonreciprocal exchange of genetic information from a ‘donor’ to an ‘acceptor’ se-
quence, primarily resulting from the repair of mismatched bases in heteroduplex recombination interme-
diates during meiosis [1]. In many cases, the process of resolving mismatches between G/C (guanine or
cytosine; denoted ‘strong’ or ‘S’) and A/T (adenine and thymine; ‘weak’ or ‘W’) alleles appears to be bi-
ased in favor of S alleles [1–3]. Such GC-biased gene conversion (gBGC) elevates the fixation probabilities
for S alleles relative to W alleles at positions of W/S polymorphism, and if it acts in a recurrent manner
over a sufficiently long time, it can result in a significant excess of W→S over S→W substitutions and a
consequent increase in equilibrium GC content. It has been known since the 1980s both that gene conver-
sion occurs in various eukaryotes [4] and that mismatch repair can be significantly biased [5]. As complete
genome sequences have become widely available, evidence has accumulated that gBGC played an impor-
tant role in genomic evolution across many branches of the tree of life. In particular, it is likely that gBGC
significantly influenced the genomic distribution of GC content, the fixation of deleterious mutations, and
rapidly evolving sequences in many species [6–13].
Aside from limited experimental evidence of a GC-bias in meiosis, mostly from yeast, much of what
is known about gBGC comes from two indirect sources of information: global patterns of variation within
or between species suggesting a fixation bias favoring S alleles [11, 12, 14–16] and the existence of numer-
ous loci exhibiting dense clusters of substitutions with a pronounced W→S bias [7–9, 13]. Both types of
evidence correlate strongly with recombination rates, consistent with a cause from gBGC, although other
recombination-associated factors might also contribute [15]. However, these observations provide limited
information about the general prevalence, strength, and functional consequences of gBGC in humans and
other mammals. Genome-wide patterns of variation are influenced by diverse forces that act in a highly
heterogeneous manner across the genome, and it is difficult to measure the specific contribution of gBGC.
Clusters of biased substitutions provide more direct evidence of a local influence from gBGC. So far, how-
ever, such clusters have been identified by considering either genomic windows of fixed size or pre-identified
genomic segments (such as protein-coding exons or fast-evolving noncoding regions), which has limited the
regions that can be detected. In addition, many studies have focused on small numbers of clusters showing
extreme substitution rates and W→S biases.
For modelers of molecular evolution, gBGC is an anomaly—a process separate and distinct from the
fundamental processes of mutation, recombination, drift, and selection that underlie most models, yet one
with the potential to profoundly influence patterns of variation within and between species. Like selection,
gBGC acts in the window between the emergence of genetic polymorphism due to mutation and its elimi-
nation due to the fixation or loss of derived alleles. Unlike selection, however, gBGC is neutral with respect
to fitness. The influence of gBGC at individual nucleotides can be modeled approximately by treating it as
a selection-like force that depends only on whether a new mutation is W→S, S→W, or neither [13, 15, 17].
However, this approach ignores the close association of gBGC with the notoriously difficult-to-model pro-
cess of recombination, which leads to a complex correlation structure along the genome (i.e., gBGC “tracts”
separated by regions of no gBGC). Owing to these difficulties, with only a few exceptions [9, 13], gBGC
has been ignored in phylogenetic or population genetic models, and considered at most in post hoc analyses
(e.g., by examining identified genomic regions for an excess of W→S substitutions). These approaches are
clearly limited in efficiency and effectiveness, and there is a need for improved models of gBGC that can be
applied on a genome-wide scale. There is also a need for high quality annotations of gBGC-affected regions
for use by investigators when interpreting comparative and population genomic analyses.
Another reason to develop improved models of gBGC is that gBGC-induced nucleotide substitutions
provide a unique window into historical recombination processes, by serving as a proxy for average re-
combination rates along a lineage of interest. By contrast, the other main sources of information about
recombination—sperm typing [18], genotypes for known pedigrees [19], and patterns of linkage disequilib-
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rium in present-day populations [20]—provide information about recombination that goes back no farther
than the coalescence time between individuals. Pronounced differences between the human and chimpanzee
recombination maps suggest that recombination rates in hominoids have changed rapidly [21–23]. gBGC
may provide useful information about the recombination processes during the critical period between the
divergence of humans and chimpanzees (4–6 million years ago [Mya]) and the coalescence time for human
individuals (∼1 Mya, on average). (Archaic hominin genome sequences are of limited use for this purpose,
because they are still few in number and would extend coalescence times only slightly.)
In this article, we address these issues by introducing a novel model-based approach for the identifi-
cation of gBGC tracts. Our approach makes use of statistical phylogenetic models that jointly consider
gBGC and natural selection [13]. In addition, it approximates the recombination-associated correlation
structure of gBGC along the genome using a hidden Markov model. We have implemented this approach in
a computer program called phastBias, which is available as part of the open-source PHylogenetic Analysis
with Space/Time models (PHAST) software package (http://compgen.bscb.cornell.edu/phast) [24]. Us-
ing simulations, we show that phastBias can identify tracts of various lengths from unannotated multiple
alignments with good power. We then analyze genome-wide predictions of gBGC tracts in the human
and chimpanzee genomes, comparing them with recombination rates, patterns of polymorphism, func-
tional elements, fast-evolving sequences, and other genomic features. This analysis sheds light on the
prevalence and fitness consequences of gBGC, and on recombination processes during the time since the
human/chimpanzee divergence. Our predictions of gBGC tracts are freely available as browser tracks
(http://genome-mirror.bscb.cornell.edu). We anticipate that these tracks will be useful for avoiding false
positives in scans for positive selection, understanding the evolution of specific loci, and investigating the
broader evolutionary forces shaping the human genome.
Results
Probabilistic Model
We model gBGC tracts using a phylogenetic hidden Markov model (phylo-HMM) with four states, repre-
senting all combinations of gBGC or no gBGC in a specified “target” genome (e.g., human or chimpanzee),
and of evolutionary conservation or no evolutionary conservation across the phylogeny (Figure 1; Methods).
The phylo-HMM framework [25] allows the distinct rates and patterns of nucleotide substitution for each
state to be described using a full statistical phylogenetic model, and it captures the pronounced correlations
along the genomes in these patterns using a first-order Markov model. Our phylo-HMM can be thought
of as a straightforward generalization of the two-state model used by the phastCons program for prediction
of evolutionarily conserved elements [26] that additionally predicts gBGC tracts in the target genome. We
directly consider evolutionary conservation together with gBGC because the dramatic reduction in substi-
tution rates in functional elements would otherwise be a confounding factor in the identification of gBGC
tracts. The model allows conserved elements and gBGC tracts to overlap or occur separately. The joint ef-
fects of gBGC and selection are modeled by treating gBGC as a selection-like force that specifically favors
the fixation of G and C alleles, as in other recent work. In particular, the influence of selection is described
using a population-scaled selection coefficient, S = 4Nes, and the influence of gBGC is described using
an analogous population-scaled GC-disparity parameter, B = 4Neb (where Ne is the effective population
size) [13] (see also [15, 17]). The parameter B measures the strength of gBGC, and values B > 0 cause
W→S substitution rates to increase and S→W substitution rates to decrease. A key feature of our approach
is that it permits identification of gBGC tracts of any length based on characteristic substitution patterns,
independent of predefined windows or genomic annotations.
Because the signal for gBGC in the data is typically quite weak, we make several assumptions to reduce
the complexity of the model. Briefly, we model negative selection as uniformly decreasing evolutionary
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rates on all lineages, we ignore positive selection, and we assume that the disparity parameter B is the
same for all gBGC tracts. In addition, we pre-estimate the parameters describing the neutral phylogeny
and evolutionary conserved elements using restricted models, we fix the tract-length parameter α based on
our prior expectation for tract lengths, and we treat the parameter B as a “tuning” parameter to be set by
trial and error (see summary of model parameters in Table 1). Our simulation study indicates that fairly high
accuracy in tract prediction is possible despite these simplifying assumptions and approximations (see below
and Methods for details). We have implemented our model in a program called phastBias in the PHAST
package [24]. PhastBias makes use of existing features in PHAST for alignment processing, phylogenetic
modeling, efficient HMM-based inference, and browser track generation.
Simulation Study
While the absence of high-quality annotations of gBGC tracts makes it difficult to assess prediction accu-
racy, we are able to gain some insight into the performance of phastBias using simulated data. To make
our simulated data as realistic as possible, we started with real genome-wide alignments, and simulated new
human sequences only, using our phylogenetic model to define neutral and conserved sequences, and inter-
spersed gBGC tracts of fixed lengths (see Methods). This strategy ensures that features such as variation in
mutation rates, changes in equilibrium GC content, conserved elements, indels, alignment errors, and miss-
ing data are all retained in the nonhuman sequences. We used phastBias to predict human-specific tracts
based on these partially simulated alignments and compared our predictions with the “true” tracts assumed
during simulation. We found that the nucleotide-level false positive rate was always very low in these ex-
periments (< 4 × 10−3 / bp), so we measured the specificity of our predictions using the nucleotide-level
positive predictive value (PPV), defined as the fraction of all bases predicted to be in gBGC tracts that truly
belong in gBGC tracts. As a measure of power, we used the nucleotide-level true positive rate (TPR), the
fraction of bases in true gBGC tracts that were correctly predicted as being in tracts.
First, we explored the performance of phastBias on simulated gBGC tracts of various lengths, generated
with several different values of the GC-disparity parameter (denoted Bsim). Under our model, increasing
Bsim produces tracts with more substitutions and greater GC bias in their substitution patterns. As expected,
both our power to detect gBGC and the specificity of our predictions increases with the lengths of the true
tracts and with Bsim (Figure 2). We found that power and specificity were both quite good for tracts of
1,000–1,500 bases or longer, provided gBGC is reasonably strong (Bsim ≥ 5). Current estimates of the
lengths and GC-disparity of real gBGC tracts [8, 27] suggest that phastBias should have good power for
many tracts (see Discussion).
Next, we examined the influence on prediction performance of our choice of the tuning parameters for
expected tract-length (α) and gBGC strength (B). We found that the performance of the method was not
highly sensitive to the value of α, so we decided to fix the expected tract length at 1 kilobase (kb) (by
setting α = 1/1000) based on empirical evidence indicating that mammalian gene conversion tracts are
approximately this size [1, 27]. By contrast, the choice of B had a much stronger influence on the observed
prediction performance. Power was highest for small values of B, regardless of the value used to simulate
the tracts (Bsim) (Supplementary Figure S1). However, this increase in power comes at only a modest
cost in PPV, which remains fairly high (>90%) except when the elements are both short and under weak
gBGC (e.g., mean lengths of 100, Bsim = 3). These results suggest that phastBias is inherently somewhat
conservative with its predictions, and that setting B to a relatively low value helps to improve sensitivity for
tracts having a range of true gBGC intensities, at minimal cost in specificity.
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Predicted gBGC Tracts
We applied phastBias to genome-wide alignments of the human, chimpanzee, orangutan, and rhesus macaque
genomes, and used it to predict tracts in the human and chimpanzee genomes likely to have experienced
gBGC since the divergence of these two species 4–6 Mya (see Methods). In separate runs, we selected
either the human or the chimpanzee genome as the “target,” and we set the tuning parameter B to values
of 2, 3, 4, 5, and 10 (in increasing strength of gBGC). As expected from our simulation study, the number,
lengths, and genomic coverage of the predicted tracts depend fairly strongly on the choice of B. In particu-
lar, coverage decreases from more than 1% to 0.07% as B is increased from 2 to 10 (Table 2). Because the
tracts predicted with highB are largely found within those predicted with lowerB (Supplementary Table S2
and because a value of B = 3 appears to result in good power while controlling false positives (see above),
we will focus on the tracts predicted with B = 3 for the remainder of the article. The absolute sensitivity of
these predictions of course depends on unknown properties of true gBGC tracts, but our simulation experi-
ments indicate that power is fairly good, at least for the subset of tracts ≥1 kb in length with a reasonably
pronounced GC-disparity (Figure 2).
With B = 3, the predictions for the human genome include 9,439 gBGC tracts covering 0.33% of the
genome (Table 2). These predicted tracts average 1,018 bp in length (median 788 bp), consistent with our
choice of α = 1/1000, but they display a fairly broad length distribution (Supplementary Figure S2), indi-
cating that our choice of tuning parameters is not overly restrictive. Most predicted tracts contain exclusively
or predominantly W→S substitutions (Supplementary Figure S3). The statistics for the chimpanzee genome
are similar, but in this case there are somewhat fewer tracts (8,677), their lengths are reduced (mean = 842
bp, median = 663 bp), and genomic coverage is about 25% lower (at 0.25%). The reduced coverage of the
chimpanzee genome holds even if we consider only tracts that completely fall within regions of high-quality,
syntenic alignment between the two genome assemblies. These differences between the human and chim-
panzee predictions could reflect differences between species in the degree to which recombination events
are concentrated in recombination hotspots [23] (see Discussion).
The human predictions are distributed across the human genome but show a clear tendency to cluster
near the ends of chromosomes (Figure 3), consistent with previous findings [12,14,28]. The median distance
from the nearest telomere is only about one third that observed for a set of GC-content-matched control
regions (9.6 megabases (Mb) vs. an average of 30.4 Mb over 1000 replicates, p < 0.001; see Methods
and Supplementary Figure S4). Similarly, the median distance between tracts is less than one third that
for the controls, even after merging tracts <1 kb apart to account for possible biases from the HMM-based
prediction method (24.3 kb vs. an average of 86.0 kb, p < 0.001). In addition to the clusters of tracts
near present-day telomeres, there is an obvious cluster near the centromere of chromosome 2, reflecting
the telomeres of two ancestral chromosomes that fused at this site sometime after the human/chimpanzee
divergence [14, 29]. The genomic distribution of the predicted tracts in chimpanzee is generally similar to
that in human (Figure 3, Supplementary Material).
Together, the human and chimpanzee tracts account for about 1.2% of all human/chimpanzee nucleotide
differences apparent in our genome-wide alignments (435,729 differences). About half (214,195) of the
nucleotide differences within the tracts can be confidently explained by W→S substitutions on either the
human or chimpanzee lineage, of which slightly more than half (115,699) fall on the human lineage. Thus,
even with our limitations in power, our predictions suggest a non-negligible influence of gBGC on overall
levels of human/chimpanzee nucleotide divergence.
Recombination Rates
The predicted human gBGC tracts are substantially enriched for recombination hotspots from the HapMap
project [30]: 1,228 (13%) overlap a hotspot, compared with an average of 796 for the control regions
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(p < 0.001). In addition, the average recombination rate [31] within these tracts is more than twice the rate
in the control regions (3.85 centimorgans per megabase (cM/Mb) vs. 1.61 cM/Mb, p < 0.001; Table 3). A
parallel analysis of the chimpanzee gBGC tracts based on the genome-wide recombination rate map from
the PanMap Project [23] showed, similarly, that recombination rates in predicted gBGC tracts were more
than twice as high as in control regions (Table 3). Pedigree-based human recombination maps [19] produced
similar results (data not shown).
At fine scales, the human and chimpanzee tracts show a modest, but significant, degree of overlap
(Figure 3): 605 (6.4%) of the human tracts directly overlap a chimpanzee tract, compared with an average
of 86 for the control regions (p < 0.001). Shared recombination hotspots account for only a small minority
(<1%) of the overlapping tracts. However, the correlation in tract locations between species is much stronger
at broader scales. For example, if the fractions of nucleotides in gBGC tracts are compared in orthologous
genomic blocks of various sizes, the human/chimpanzee Pearson’s correlation increases from r = 0.25 for
10 kb blocks to r = 0.57 for 100 kb blocks, and to r = 0.80 for 1 Mb blocks (Supplementary Figure S5).
These observations mirror those for human and chimpanzee recombination rates, which correlate well at
scales of 1 Mb or larger but much more poorly at finer scales [21–23].
To gain further insight into the conservation of the gBGC tracts, we mapped the human gBGC tracts
to orthologous locations in the chimpanzee genome, and the chimpanzee tracts to orthologous locations in
the human genome. We then compared the recombination rates in these “ortho-tracts” with those in control
regions, as with the tracts predicted for each species. Unlike recombination hotspots [23], the predicted
gBGC tracts show significantly elevated recombination rates at orthologous positions in the other species
(Table 3). However, these recombination rates are not nearly as elevated as those in the genome in which the
tracts were predicted. Together, these observations indicate that, while the human and chimpanzee gBGC
tracts are only weakly correlated, they nevertheless exhibit residual correlation beyond what is observed with
present-day recombination rates, probably because they reflect average recombination rates over millions of
years (see Discussion).
In both human and chimpanzee, the predicted tracts show a weak positive correlation with GC-content
on a megabase scale. This correlation is somewhat stronger for human (Pearson’s correlation for 1 Mb
blocks: r = 0.12) than for chimpanzee (r = 0.09), mirroring observations of a stronger correlation of
recombination rate with GC-content in human than in chimpanzee [23].
Genomic Annotations
To shed light on the functional implications of gBGC, we examined the degree of overlap of the predicted
human gBGC tracts with various sets of genomic annotations (listed in Methods). In comparison with the
control regions, we found that the human gBGC tracts were significantly depleted for overlap with known
protein-coding exons, core promoters (1 kb upstream of annotated transcription start sites), miscellaneous
RNAs, LINEs and SINEs, while they were significantly enriched for overlap with introns, lincRNAs, and a
collection of ChIP-seq-supported transcription factor binding sites (Supplementary Figure S6). However, all
of these enrichments and depletions were modest in magnitude, with fold-changes of about 0.8–1.3. Overall,
the gBGC tracts appear to be fairly representative of sequences of the same GC content. It is possible that the
depletion for gBGC tracts in protein-coding exons and promoters could result in part from strong purifying
selection counteracting GC-biased fixation.
GC-Bias in Derived Alleles
To distinguish between fixation- and mutation-related biases, we compared the derived allele frequencies at
polymorphic W→S and S→W sites in the predicted tracts and control regions. To control for the possibility
of an ascertainment bias from polymorphic sites at which the derived allele is present in the human reference
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genome, we performed this analysis twice: once with the original gBGC tracts, and once with predictions
based on alignments in which polymorphic sites in the human genome had been masked with ‘N’s.
Based on data from the 1000 Genomes Project [31] (YRI population), the predicted gBGC tracts dis-
played significantly elevated derived allele frequencies at sites of inferred W→S mutations compared with
sites of inferred S→W mutations (W→S DAF skew of 0.723 ± 0.006; Figure 4A). This skew in DAFs was
significantly greater than that observed genome-wide (0.558 ± 0.001) or in recombination hotspots (0.595
± 0.008; Figure 4B), and it was larger than observed in any of the 1000 control region replicates (0.573
± 0.009). The tracts are also far more biased than any of the regions considered by Katzman et al. [16],
which were identified using sliding windows of fixed size and likely contained a mixture of gBGC tracts and
non-tracts. Results were similar for the CEU (0.703 ± 0.007) and CHB-JPT populations (0.678 ± 0.008).
These results held for the tracts based on the polymorphism-masked alignments, although the magnitude of
the skew was somewhat reduced in this case (0.685 ± 0.007 for YRI; Supplementary Figure S7). Together,
these results strongly indicate an on-going preference for the fixation of G and C alleles in the predicted
gBGC tracts.
Fixation of Deleterious Alleles
Theoretical modeling has shown that gBGC, in principle, can overcome negative selection and result in the
fixation of weakly deleterious alleles [3,8,10]. However, there is currently little direct empirical evidence of
a contribution of gBGC to fixed or segregating deleterious alleles [11]. Our genome-wide tract predictions
enabled us to investigate the link between gBGC and deleterious alleles in two ways: by testing for en-
richments for disease-associated genomic regions in gBGC tracts, and by examining evidence of purifying
selection in orthologous regions of other mammalian genomes.
First, we examined the relationship between the gBGC tracts and four sets of putatively disease-assoc-
iated genomic regions: 10,711 polymorphic sites from dbSNP annotated as “pathogenic” or “probable
pathogenic” [32]; 43,952 polymorphic sites from the Human Gene Mutation Database (HGMD) [33] (see
also [11]); 11,444 genomic regions from the Genetic Association Database (GAD) [34]; and 6,435,165 poly-
morphic sites with evidence of functional importance (classes 1–5) in RegulomeDB [35]. For the dbSNP
pathogenic and HGMD comparisons, we considered sets of control regions that overlapped the same num-
ber of exonic SNPs as the gBGC tracts. This control is designed to avoid misleading findings of significance
that simply reflect the GC content, exon coverage, and/or rates of polymorphism in the gBGC tracts, since
these disease-associated region sets are mostly found in coding regions. Similarly, we used control regions
matched to SNPs considered by RegulomeDB, since it only includes non-coding SNPs (Methods). We
found that the gBGC tracts overlapped significantly more putatively disease-related SNPs from the dbSNP,
HGMD, and RegulomeDB collections, and significantly more of the GAD regions, than did the matched
control regions (Table 4; p < 0.05 for each).
Second, we looked for evidence of purifying selection in chimpanzees and other species at the loca-
tions of W→S substitutions within the predicted human tracts. If a substantial number of these mutations
were driven to fixation by gBGC despite negative selection against them, we would expect to observe an
excess of evolutionary conservation, a deficiency of polymorphisms, and/or a skew toward low-frequency
derived alleles at orthologous locations in other species. However, we found that the bulk distributions of
phyloP conservation scores [36], computed for eutherian mammals but excluding human and chimpanzee
(Methods), were nearly identical for the tracts and the GC-matched controls (Supplementary Figure S8).
In addition, we compared chimpanzee polymorphisms [23] in regions orthologous to our human tracts and
control regions, and found no deficiency of polymorphisms (Supplementary Figure S9) and no excess of
low-frequency derived alleles (Supplementary Figure S10) within the tracts. Indeed, the regions ortholo-
gous to the human tracts displayed an excess of chimp polymorphisms, perhaps reflecting increased power
for gBGC detection in regions of elevated mutation rates. On the other hand, we did observe a significant en-
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richment for overlap with evolutionarily conserved elements identified using phastCons [26] at locations of
W→S substitutions within the predicted tracts (Supplementary Figure S11). Thus, we found mixed evidence
linking gBGC with fixation of deleterious alleles.
Overlap with Fast-Evolving Sequences
Many fast-evolving regions of the human genome display an excess of W→S substitutions, leading to the
suggestion that gBGC may play a role in their evolution [6, 7, 9, 13, 37, 38]. Supporting this hypothesis,
our predicted gBGC tracts overlap 13 of the 202 (6.4%) HARs identified by Pollard et al. [37], more than
observed for any of the 1000 GC-control region replicates (p < 0.001). Notably, the HARs overlapped by
gBGC tracts included HAR1, HAR2, and HAR3, the three fastest evolving sequences in this set. We also
examined an expanded set of 721 HARs [39] and found that gBGC tracts overlapped 75 of them (10%;
p < 0.001; see example in Figure 5). Next, we compared the gBGC tracts with the 10 protein-coding genes
recently identified as showing signatures of positive selection on the human branch based on a likelihood
ratio test [40]. One of these genes is overlapped by a gBGC tract, significantly more than expected based
on exon-aware controls (p = 0.009). The overlapped gene, ADCYAP1, was also highlighted by another
group [9] as showing strong evidence of an influence from gBGC. We repeated our analysis with 157 genes
identified in another recent study as showing signatures of human-specific positive selection [41], and found
that the gBGC tracts overlapped 11 (7%) of these genes, somewhat more than average for the exon-aware
control replicates (7.4, p = 0.077). Considering our limitations in power (see Discussion), these results
indicate the gBGC has contributed to a substantial fraction of fast-evolving sequences in the human genome.
Genome Browser Track
Our predicted tracts for human and chimpanzee are available as a UCSC Genome Browser track at http:
//genome-mirror.bscb.cornell.edu (Figure 5). This track displays both our discrete predictions of gBGC
tracts and a continuous-valued plot indicating the posterior probability that each position is influenced by
gBGC. Using this track it is possible to browse the predicted tracts in their full genomic context, perform
queries intersecting them with other browser tracks, and download them for further analysis. We expect
this track to be particularly useful for other investigators who wish to exclude gBGC-influenced regions of
the genome from other molecular evolutionary analyses, such as the identification of genes under positive
selection. The tracts themselves will also be directly useful for studying the evolution of recombination rates
and their relationship to substitution rates and patterns.
Discussion
This paper describes an analysis of predicted gBGC tracts in the human and chimpanzee genomes, based on a
new computational method called phastBias. PhastBias makes use of a hidden Markov model and statistical
phylogenetic models that consider the influence of both natural selection and gBGC on substitution rates
and patterns. Unlike previous methods for identifying signatures of gBGC, it does not depend on a sliding
window or previous genomic annotations, but instead can flexibly identify tracts of various sizes directly
from genome-scale multiple alignments. The method appears to have good power for tracts of about 1
kilobase or longer, provided gBGC has acted with a reasonably high average intensity along the lineage
of interest. Our predictions in the human and chimpanzee genomes cover about 0.3% of each genome,
and explain about 1.2% of human/chimpanzee single nucleotide differences. Consistent with a cause from
gBGC, the predicted tracts are correlated with recombination rates, tend to fall in subtelomeric regions, and
exhibit an ongoing fixation bias for G and C alleles. In addition, they tend to overlap previously identified
fast-evolving coding and non-coding regions, suggesting that gBGC has contributed significantly to the
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evolution of these sequences. Overall, our analyses indicate that gBGC has been an important force in the
evolution of human and chimpanzees since their divergence 4–6 million years ago.
Many attributes of the predicted gBGC tracts are consistent with recombination as the driving force
of gBGC. Nevertheless, the tract locations are only partially correlated with recombination rates in human
and chimpanzee. Moreover, while the tracts are enriched for recombination hotspots in both species, there
are thousands of hotspots that do not overlap a gBGC tract, and the majority of tracts do not overlap a
hotspot. These differences can be explained by several factors. First, the hotspots we have analyzed reflect
recombination patterns in modern human populations, while the gBGC tracts reflect average patterns since
the divergence of humans and chimpanzees. Many current hotspots presumably have not had sufficient
time to produce a detectable signature of biased substitution, while many extinct hotspots contributed to
gBGC for long periods of time in the past. The gBGC imprint of such historical recombination hotspots
can be observed most dramatically near the fusion of chromosome 2 (Figure 3). Second, models of gBGC
suggest that it can occur in conjunction with both crossover and noncrossover recombination events, but
current recombination maps reflect crossover events only [3]. An imperfect correlation of these types of
events, together with statistical noise in current estimates of crossover rates, likely accounts for some of the
absence of correlation between recombination rates and gBGC tracts. Finally, biased substitution rates are
influenced by factors other than recombination, such as mutation rates and natural selection. For example,
strong purifying selection at or near a hotspot could eliminate the signature of gBGC.
The locations of the human and chimpanzee tracts are strongly correlated on megabase scales, but, like
recombination rates, they differ significantly on fine scales, and few human and chimpanzee tracts directly
overlap one another (Figure 3; Supplementary Figure S5). Nevertheless, even at fine scales, the gBGC
tracts for the two species agree better than recombination hotspots, which are essentially uncorrelated [23].
This observation probably stems from the fact that gBGC tracts reflect time-averaged recombination rates,
and historical recombination rates were presumably better correlated than those in present-day humans and
chimpanzees. In general, the predicted gBGC tracts provide a valuable window into historical recombination
processes, but this window is “blurred” by time-averaging over millions of years. Nevertheless, together
with other sources of information about historical recombination processes—such as new methods based
on patterns of incomplete lineage sorting (K. Munch, T. Mailund, J.Y. Dutheil, and M.H. Schierup, in
prep.)—predictions of gBGC tracts may help to fill in our picture of the evolution of recombination rates in
hominoids.
Despite the overall similarity of the human and chimpanzee predictions, the coverage of the predicted
tracts is about 25% lower in the chimpanzee genome. A possible cause of this difference is the greater con-
centration of recombination events in hotspots in humans [23]. This difference could lead to a stronger
population-level signal for gBGC in humans, allowing for more predictions and longer predicted tract
lengths. Because this concentration of recombination events is more pronounced for European than for
African populations, it may be of interest to predict separate sets of tracts for individuals of European and
African descent and see whether an excess of gBGC tracts are observed in Europeans.
The difference between humans and chimpanzees in the concentration of recombination events may
derive from differences in the activity of the hotspot-specifying protein PRDM9, which shows substantially
greater allelic diversity in chimpanzees than in humans [23]. Consistent with this hypothesis, there is a
much weaker signal for sequence motifs potentially involved in PRDM9 binding at chimpanzee hotspots
than at human hotspots. In an attempt to shed light on the ancestral binding preferences of PRDM9, we
applied motif discovery methods to the predicted gBGC tracts in the human and chimpanzee genomes.
However, in both species this analysis turned up only a few motifs, none of which resembled the well-
defined motifs reported for the human genome [23, 42]. It may be that the ancestral recombination hotspots
in both species are more like the ones in present-day chimpanzees than those in present-day humans, with
poorly defined sequence motifs. Alternatively, the absence of well-defined motifs may simply reflect rapidly
evolving PRDM9 binding preferences and the time-averaged nature of the gBGC tracts, which together
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could eliminate a clear signal for motif discovery.
Given what is currently known about gBGC, it is impossible to obtain direct measurements of the com-
pleteness and accuracy of our predicted tracts. Our simulation experiments suggest that both sensitivity and
specificity are reasonably good for tracts at least 1–2 kb in length with B ≥ 5, but we often miss shorter
or less biased gBGC tracts (Figure 2), and the true distributions of tract lengths and B values are unknown
(although estimates of B = 1.3 [43] and B = 8.7 [8] have been reported for highly recombining regions).
It is important to bear in mind that B represents an average along an entire branch of the phylogeny. Many
regions may have experienced quite strong gBGC but for short evolutionary intervals, resulting in small
average values of B and poor detection power. Thus, while our genome-wide predictions improve on what
is currently available, it seems plausible that they still represent the “tip of the iceberg”—a relatively small
subset of all genomic regions significantly influenced by gBGC, perhaps unusual for their length or GC-
disparity.
It is worthwhile to consider two other indirect sources of information about our power for gBGC tract
prediction. First, Katzman et al. [16] found that about 20% of the 40 kb genomic intervals they examined
show significant W→S DAF skew. If we conservatively assume one 1–2 kb tract per gBGC-influenced
window, this observation would imply that at least 0.5–1.0% of the human genome has been influenced
by gBGC on population genomic time scales, compared with the phastBias estimate (for B = 3) of 0.3%.
Second, using a method optimized for the analysis of individual HARs, Kostka et al. [13] estimated that 24%
of HARs experienced significant gBGC (19% exclusively and 5% in combination with positive selection),
or 3.7 times as many as overlap our phastBias predictions (6.4%). Thus, these two imperfect indicators
of power suggest that, with B = 3, phastBias underpredicts gBGC tracts by a factor of roughly 2–4 or
more. The genomic coverage of our B = 2 predictions may be closer to the truth (1.1%; Table 2), but these
predictions appeared to be of poorer quality on inspection, apparently because the phylo-HMM states with
and without gBGC were insufficiently distinct to control false positive rates.
It is also worth noting that, while the likelihood ratio tests of Kostka et al. [13] appeared to have greater
power for gBGC in HARs overall, phastBias sometimes achieves improved sensitivity by considering the
entire genome (including flanking sequences) rather than just a designated collection of elements. Indeed, of
the thirteen HARs that overlap one of our gBGC tracts, three were not identified by Kostka et al., apparently
for this reason. These instances of improved sensitivity are especially noteworthy given that phastBias must
address the more difficult problem of unconstrained genome-wide prediction, with the attendant potential
for large numbers of false positives predictions.
In principle, gBGC can overcome purifying selection and help to drive deleterious alleles to high fre-
quencies [3,8,10], but it has been difficult to find direct empirical evidence for a reduction in fitness (genetic
load) caused by gBGC. Our predicted gBGC tracts provide two hints of an empirical link between gBGC and
fitness reductions. First, the predicted tracts are significantly enriched for disease-associated polymorphisms
in current human populations, suggesting that gBGC has helped to drive at least some of these alleles to ap-
preciable frequencies, and, indeed, may still be active in maintaining these deleterious alleles. Second, the
inferred W→S substitutions in the tracts are enriched for overlap with evolutionarily conserved sequences in
eutherian mammals, suggesting long-term purifying selection against the (presumably) gBGC-driven G/C
allele at some of these positions. However, other lines of evidence were inconsistent with these findings,
and despite several attempts (Supplementary Material), we were unable to obtain reliable estimates of the
overall contribution of gBGC to deleterious substitutions in the human genome. This estimation problem is
difficult because many correlates of gBGC are also correlates of nucleotide substitution rates, and because
most gBGC-induced substitutions are probably neutral, with only a small fraction being deleterious. This
will be an interesting and important topic for future work.
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Methods
Probabilistic Model
Our phylogenetic hidden Markov model has four states: one that assumes both evolutionary conservation
and gBGC (CB), a second with gBGC but no conservation (NB), a third with conservation but no gBGC
(C0), and a fourth with neither conservation nor gBGC (N0) (Figure 1). To avoid over-parameterization, we
make the following simplifying assumptions. First, we model gBGC only on the lineage leading to a pre-
defined “target” genome (human or chimpanzee), because gBGC is expected to be a transient phenomenon,
typically affecting a single lineage in any genomic position of interest. gBGC tracts are allowed to occur
on other lineages, but these tracts are expected to have a negligible influence on inferences in the target
genome and are not directly modeled. Second, negative selection, in contrast to gBGC, is assumed to apply
uniformly across all branches of the phylogeny. Third, positive selection is ignored. We omit positive
selection and lineage-specific negative selection from the model because they are expected to be fairly
rare, to leave a relatively weak signal in the data at human-chimpanzee evolutionary distances [44], and to
primarily operate at a somewhat different genomic scale from gBGC (e.g., at the level of individual binding
sites or clusters of amino acids, rather than genomic tracts of hundreds or thousands of bases). We expect
our modeling framework to be robust to occasional sequences under positive or lineage-specific selection,
because the primary signal for tract prediction is a W→S substitution bias, and selection generally will not
produce such a bias consistently across many bases. Finally, we assume that the strength of gBGC and the
strength of negative selection in the target genome are constant across the genome. A similar homogeneity
assumption is employed in phastCons and appears to have a minimal impact on power and accuracy for
element identification [26].
With these assumptions, the phylogenetic models for the four states are defined as follows.
1. Neutral/No gBGC (N0): Neutral evolution is described by an HKY substitution model [45], with
free parameters for the transition/transversion ratio (κ) and stationary nucleotide frequencies (pi).
We assume the accepted tree topology for the species under consideration: (((human, chimpanzee),
orangutan), rhesus macaque). The branch length proportions were obtained from the Conservation
tracks in the UCSC Genome Browser (assembly hg18) [46]. (They were originally estimated from
fourfold degenerate sites in protein coding genes under a strand-symmetric general reversible model.)
These branches were scaled locally to accommodate regional variation in mutation rate (see below).
2. Neutral/gBGC (NB): This model is identical to the neutral model except that it assumes gBGC in-
fluences substitution rates and patterns on the lineage leading to the target species (human or chim-
panzee) according to the model of Kostka et al. [13]. The strength of gBGC is described by the
GC-disparity parameter B > 0, which increases the rate of W→S substitutions and decreases the rate
of S→W substitutions.
3. Conserved/No gBGC (C0): Evolutionary conservation is modeled, as in phastCons, by multiplying
the branch lengths of the neutral model by a factor ρ (0 ≤ ρ ≤ 1). In all other respects, this model is
identical to the neutral model. Note that the application of a multiplicative scale factor to the neutral
branch lengths is mathematically equivalent to selecting a constant value for the population-scaled
selection coefficient S in the joint BGC/selection model of Kostka et al. [13].
4. Conserved/gBGC (CB): This model is identical to model NB except that it assumes gBGC acts with
strength B on the lineage leading to the target species.
The state-transition probabilities are defined by four parameters, denoted µ, ν, α, and β (Figure 1, Ta-
ble 1). The parameters µ and ν are inherited from phastCons [26] and describe the conditional probabilities
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of transitioning from a conserved state to a neutral state, and from a neutral state to a conserved state, re-
spectively. The parameters α and β are analogous, defining the conditional probabilities of transitioning
out of, and into, a gBGC tract, respectively. The sixteen possible state transition probabilities are obtained
by multiplying the appropriate pairs of conditional probabilities and enforcing the standard normalization
constraints (Figure 1). This “cross-product” construction corresponds to a prior assumption of independence
for the two types of transitions (conservation↔ no conservation and gBGC↔ no gBGC).
Given a multiple sequence alignment, standard algorithms for statistical phylogenetics and hidden Markov
models can be used to calculate the likelihood of the data under this model, to predict the most likely state
path (Viterbi), or to calculate the marginal posterior probability of each state at each alignment column
(reviewed in [25]).
Parameter Estimation
In principle, the nine free parameters in our model (Table 1) could all be estimated directly from the data by
maximum likelihood, using an expectation maximization or numerical optimization algorithm. In practice,
however, parameter estimation is difficult because there are no validated gBGC tracts to use for supervised
training of the model, and the signal in the data is not sufficiently strong to support a fully unsupervised es-
timation procedure. Instead, we partition the parameters into three groups: those for the neutral substitution
process, those for the model of conserved elements, and those specific to the gBGC tracts. The first two
groups of parameters are pre-estimated from the data without consideration of gBGC, by what can be con-
sidered an empirical Bayes approach. The parameters in the third group are then estimated by a combination
of methods.
Specifically, the free parameters for the neutral substitution process (λ, pi, and κ) are estimated per
alignment block (see below) using phyloFit [24], after conditioning on the tree topology and branch-length
proportions (as described above). This strategy assumes that conserved elements and gBGC tracts are sparse
and have at most a minor effect on average substitution rates for large genomic blocks. The three additional
parameters that describe conserved elements (ρ, µ, and ν) are inherited directly from phastCons and there-
fore were simply set to the values used for the Conservation tracks in the UCSC Genome Browser. The
remaining parameters include the GC-disparity B and the gBGC transition probabilities α and β. As dis-
cussed in the Results section, we found that α—which can be interpreted as an inverse prior expected length
for gBGC tracts—has only a weak influence on our predictions (within a reasonable range) and decided to
simply fix it at 1/1000, corresponding to a prior expectation of 1 kb tracts. We treatedB as a “tuning” param-
eter and considered various possible values in a plausible range. The final parameter, β, was estimated from
the data (separately for each alignment block) by expectation maximization, conditional on fixed values of
all other parameters.
Tract Prediction
To predict gBGC tracts based on our model, we computed marginal posterior probabilities for the four model
states at each genomic position using the forward/backward algorithm. We then computed the marginal
posterior probability of gBGC by summing the probabilities for states NB and CB , and we predicted tracts by
applying a threshold of 0.5 to this probability (i.e., the predicted tracts are maximal segments in which every
position has a posterior probability of at least 50% of gBGC). We settled on this strategy after discovering
that the more conventional Viterbi algorithm performed poorly in this setting, evidently due to uncertainty
about the endpoints of tracts. This uncertainty causes the probability mass for a putative gBGC tract to be
distributed across many possible HMM state paths, and as a result, the Viterbi algorithm often fails to predict
a tract even when the posterior probability of gBGC is close to one. A potential drawback of our thresholding
strategy is that fluctuating posterior probabilities could lead to highly fragmented tract predictions. However,
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we found that the posterior probability function was quite smooth in practice (probably owing to small values
of the state transition probabilities) and fragmentation was not a problem. For example, atB = 3, only about
2% of the predicted human tracts fall within 50 base pairs of another tract. Nonetheless, when analyzing
the genomic distribution of gBGC tracts relative to one another and to telomeres, we merged adjacent tracts
(within 1 kb) in order to reduce any bias introduced by over fragmentation (Supplementary Material).
Genome-wide Alignments and Preprocessing
Our analyses of both simulated and real data were based on genome-wide alignments obtained from the
UCSC Genome Browser (http://genome.ucsc.edu) [46]. We began with the 44-way vertebrate alignments
produced with multiz [47] (hg18 assembly) and extracted the rows corresponding to the human, chimpanzee,
orangutan, and rhesus macaque genomes, discarding alignment columns containing only gaps in these se-
quences. We also discarded columns in which the human genome contained a gap. Human-referenced
alignments were used for both the human and chimpanzee gBGC tract predictions, as chimpanzee-based
multiple alignments are not available. For convenience in processing, the resulting four-way alignments
were partitioned into blocks of approximately 10 megabases (Mb) in length. The boundaries between blocks
were required to occur in regions uninformative about gBGC (due to >1 kb with lack of alignment with the
other species).
Simulation Study
We simulated human sequences with gBGC tracts for each 10 Mb block in the real genome-wide alignments
as follows. First, we identified positions at which any sequence contained a CpG dinucleotide, because sub-
stitution rates are likely to be substantially elevated at such sites. Next, we used phastCons to identify
conserved elements in the four species. We then fitted a phylogenetic model to the alignment columns in
each of four categories (neutral/non-CpG, conserved/non-CpG, neutral/CpG, conserved/CpG) by estimat-
ing κ, pi, and λ for the most data-rich category (neutral/non-CpG), then estimating a separate λ for the
CpG category (using phyloFit) and applying a branch-length scale-factor of 0.3 to the conserved categories.
Next, we defined an alternative “gBGC” instance of each of the four estimated models by modifying the
substitution rate matrix for the human branch according to our model of gBGC [13] and a given choice of
B (here denoted Bsim). In this way, we obtained eight phylogenetic models, representing all combinations
of conservation / no conservation, CpG / no CpG, and gBGC / no gBGC.
We generated synthetic human sequences by assigning one of these eight models to each alignment col-
umn, as follows. The conservation and CpG status of each column was maintained as originally annotated,
so that the synthetic alignments would resemble the original ones as much as possible. The gBGC status
was set to “no gBGC” for most columns, but set to “gBGC” for tracts of fixed size at randomly selected
locations, at an average gBGC coverage of 0.1%. We then simulated a new human base for each alignment
column conditional on the assigned phylogenetic model and the observed chimpanzee, orangutan, and rhe-
sus macaque bases. This was accomplished using the ‘postprob.msa’ function in RPHAST, which computes
the marginal distribution over bases at any node in the phylogeny conditional on a given phylogenetic model
and collection of observed bases, using the sum-product algorithm. This function computes the desired dis-
tribution for the human base if the human sequence is masked and treated as missing data in the input. A
particular base was selected by sampling from this marginal distribution.
We performed this simulation procedure for combinations of Bsim ∈ {3, 5, 10} and fixed tract lengths
of 200, 400, 800, 1600, 3200, and 6400. For each set of simulated alignments, we predicted gBGC tracts
as described in the previous section, assuming several different values for the tuning parameter B. For each
data set and value of B, we calculated the true positive rate (number of correctly predicted gBGC bases /
total number of gBGC bases), false positive rate (number of incorrectly predicted gBGC bases / total number
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of non-gBGC bases), and positive predictive value (number of correctly predicted gBGC bases / number of
predicted gBGC bases).
Genomic Annotations
We compared the predicted gBGC tracts with exon and intron definitions from Gencode version 3c and En-
sembl genes [48], and with annotations of lincRNAs, miRNAs, miscRNAs, small non-coding RNAs, NMD
transcripts, and pseudogenes from Gencode version 14 [49]. We also compared them with LINE and SINE
elements from the rmskRM327 table in the UCSC Table Browser [50], and with a set of high-confidence
predictions of transcription factor binding sites based on ChIP-seq data from ENCODE [51] (L. Arbiza,
I. Gronau, B.A. Aksoy, M.J. Hubisz, B. Gulko, A. Keinan, and A. Siepel, in revision). In addition, we
compared the tracts with genome-wide recombination rate estimates from the 1000 Genomes Project [31],
recombination hotspots from the October 2006 release of HapMap [30], and chimpanzee recombination rate
estimates from the PanMap project [23].
Disease-associated SNPs were obtained from several sources. SNPs annotated with “pathogenic” or
“probable pathogenic” clinical significance were downloaded on October, 25, 2011 from dbSNP [32].
The HGMD dSNPs were obtained from the Supplementary Material of reference [11]. Regions of the
human genome with positive genetic associations with disease were taken from the Genetic Association
Database [34] on February 2, 2012. The level of evidence for the function of non-coding SNPs was
downloaded from the RegulomeDB [35] web site on December 12, 2012. All data not in reference to the
GRCh36/hg18 assembly were mapped to hg18 using the ‘liftOver’ tool from the UCSC Genome Browser.
Control Regions
To evaluate the statistical significance of various properties of interest, we compared the predicted gBGC
tracts with sets of control regions matched to them in number, length distribution, and chromosome as-
signment. We also ensured that the control regions were matched to the gBGC tracts by GC content (by
stratifying predictions and controls into 100 bins), which is known to correlate strongly with several rele-
vant genomic features. We obtained a null distribution for each statistic of interest (such as the number of
tracts overlapping exons, or the number human tracts overlapping orthologous chimpanzee tracts), by com-
puting a value of the statistic for each of 1000 randomly sampled replicates of the control regions. One-sided
empirical p-values were computed as the fraction of sampled control sets for which the statistic was at least
as extreme as observed in the predicted tracts. As noted in the text, we occasionally considered alternative
sets of control regions designed to accommodate known biases in genomic regions of interest. For exam-
ple, when evaluating the significance of overlap with disease-associated SNPs from HGMD and dbSNP, we
used control regions matched to the predicted tracts in terms of their degree of exon overlap, since these
sets consist mostly of coding SNPs. Similarly, for RegulomeDB, which is focused on non-coding SNPs,
we used control regions that matched the overlap of the gBGC tracts with the set of SNPs considered by
RegulomeDB.
Analysis of Derived Allele Frequencies
Our analysis of derived allele frequences was based on genotype data from the low-coverage pilot data set
from the 1000 Genomes Project released in July 2010 [31]. These comprise SNP calls for the 22 auto-
somes in three HapMap population panels: YRI (59 individuals), CEU (60 individuals), and CHB-JPT (60
individuals). We computed the W→S DAF skew of all gBGC tract SNPs as normalized U values from
a Mann-Whitney U test on the derived allele frequencies of W→S and S→W SNPs, as previously de-
scribed [16]. A W→S DAF skew of 0.5 indicates no bias, and values greater than 0.5 indicate that W→S
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mutations are favored.
Purifying Selection at Orthologous Positions
We evaluated evidence of purifying selection at regions of other mammalian genomes by considering (1)
evolutionary conservation scores for mammals and (2) patterns of polymorphism in chimpanzee. In both
cases, we compared regions orthologous to the predicted human tracts and regions orthologous to control
regions. The first comparison used phyloP CONACC conservation scores [36] at positions of human-specific
W→S substitutions within the predicted tracts. To avoid possible biases from human-specific substitutions
or from the chimpanzee sequence used to assign these substitutions to the human branch, we re-computed the
phyloP scores based on alignments of eutherian mammals from which the human and chimpanzee sequences
had been removed (leaving 30 mammalian species). We compared the tracts with both exon- and GC-
matched control regions (Supplementary Figure S8). For the polymorphism analysis, we used data from the
PanMap Project [23] and considered all nucleotides within the predicted tracts, because the subset of sites
with both human-specific W→S substitutions and chimpanzee polymorphisms was very small (42 sites).
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Tables
Table 1. Summary of HMM parameters
Parameter Groupa Description Value
λ neut Scale factor for neutral branch lengths estimated per 10 Mb block
pib neut Equilibrium nucleotide frequencies estimated per 10 Mb block
κ neut Transition/transversion ratio estimated per 10 Mb block
ρ cons Branch length scale factor in conserved state 0.3c
µ cons Transition prob. conserved→neutral 0.022c
ν cons Transition prob. neutral→conserved 0.0095c
B gBGC GC-disparity (strength of gBGC) 2, 3d, 4, 5, 10
α gBGC Transition prob. gBGC→non-gBGC 0.001e
β gBGC Transition prob. non-gBGC→gBGC optimized by EM
aneut = parameters for neutral phylogenetic model, cons = parameters for conserved elements (inherited from phast-
Cons), gBGC = parameters for gBGC tracts.
bMultivariate parameter (three degrees of freedom).
cValues used for the Conservation tracks in the UCSC Genome Browser (see [26]).
dValue used for primary analyses.
eCorresponds to prior expected length of 1 kb.
Table 2. Summary of predicted gBGC tracts
Species B Number Coverage Mean length Median length
Human 2 12362 1.103% 2567 1008
Human 3 9439 0.334% 1018 788
Human 4 7712 0.217% 810 628
Human 5 6750 0.157% 670 514
Human 10 5210 0.073% 400 276
Chimpanzee 3 8677 0.252% 841 663
Chimpanzee 10 7062 0.068% 278 198
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Table 3. Recombination rates in gBGC tracts
Recombination Human gBGC tract Chimpanzee gBGC tract GC-matched Control
Map Rate (cM /Mb) Rate (cM /Mb) Rate (cM /Mb)
Human 3.85 1.81a 1.61
Chimpanzee 1.33b 1.71 0.78
aObtained by mapping chimpanzee tracts to orthologous positions in the human genome.
bObtained by mapping human tracts to orthologous positions in the chimpanzee genome.
Table 4. Enrichment for disease-associated regions
Disease-associated gBGC Tract Avg. Control
Region Set Overlap Overlap p-value
dbSNP Pathogenic 113 46.3 0.005
HGMD 346 178.2 0.031
RegulomeDB (classes 1–5) 26474 20768.4 <0.001
GAD 485 419.7 <0.001
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Figure 1. Phylogenetic hidden Markov model used by phastBias. The model consists of four states:
neutral evolution with no gBGC (N0), neutral evolution with gBGC (NB), evolutionary conservation with
no gBGC (C0), and evolutionary conservation with gBGC (CB). gBGC is assumed to influence nucleotide
substitution rates and patterns only on the lineage leading to a designated target genome (human or
chimpanzee in this study). The model generalizes the phylo-HMM used by phastCons for prediction of
evolutionarily conserved elements [26]. The state transition probabilities are defined by four parameters,
denoted µ, ν, α, and β. See Methods and Table 1 for details.
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Figure 2. Power and accuracy for simulated data. The plot shows true positive rates (TPR; fraction of
true gBGC bases correctly predicted) and positive predictive values (PPV; fraction of predicted bases in
true gBGC tracts) as a function of tract length. Results are shown for two sets of simulations, one assuming
strong BGC (Bsim = 10), and the other assuming weaker BGC (Bsim = 5) (see Methods). Both the power
(as measured by the TPR) and the accuracy (as measured by PPV) of gBGC detection depend strongly on
tract length. At shorter lengths (<3000 bp) power also depends strongly on the strength of gBGC, while
accuracy does not. Both TPR and PPV are fairly high (∼80% or more) for tracts of ≥1 kb that have
experienced strong gBGC, and for tracts of ≥1.6 kb that have experienced weaker gBGC.
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Figure 3. Genomic distribution of predicted human and chimpanzee gBGC tracts. Both human (blue)
and chimpanzee (red) gBGC tracts are found throughout the genome, but tend to cluster and fall near
telomeres. Chimpanzee gBGC tracts are displayed at the corresponding aligned positions in the human
genome. The dense cluster of gBGC tracts near the centromere of chromosome 2 is the site of the fusion of
two ancestral chromosomes on the human lineage. This region is telomeric in chimpanzee and was
telomeric for much of human evolution. As illustrated by the magnified section of chromosome 1, human
and chimpanzee tracts often occur in similar regions, but rarely overlap.
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Figure 4. Human polymorphism data indicates an ongoing preference for the fixation of G and C
alleles in the predicted gBGC tracts. (A) W→S changes in gBGC tracts have significantly higher derived
allele frequencies than S→W changes in tracts. This plot is based on data for the YRI population from the
1000 Genomes Project [31]. Results for other populations were similar (data not shown). (B) The U -norm,
a measure of the degree of W→S bias [16], is significantly higher in gBGC tracts than in the entire genome
or in GC-matched control regions (see Methods). Recombination hotspots also show somewhat elevated
values but much less elevated than the predicted tracts. The error bars indicate 95% confidence intervals.
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Figure 5. Illustration of genome browser track. (A) UCSC Genome Browser screen shot focused on the
LMAN1 gene (hg18.chr18:55,148,088-55,177,461). This region contains a predicted gBGC tract (black
bar, second track from top); the “wiggle” track below shows the posterior probability of gBGC at each site
computed by phastBias. The gBGC tract overlaps an exon of the gene (blue bar at top; adjacent chevrons
indicate introns), a human accelerated region (2xHAR.23; short black bar), and a known missense variant
from dbSNP (rs146465318; black tick mark). The phyloP-based conservation track (“Mammal Cons”)
shows that phastBias can predict tracts that span both conserved and nonconserved regions. The phastBias
track is available at http://genome-mirror.bscb.cornell.edu (hg18 assembly). Notably, this region has an
elevated recombination rate (2.5 cM/Mb; not shown). (B) The multiple sequence alignment for a portion of
the gBGC tract (hg18.chr18:55,171,469-55,171,548) illustrates the characteristic signature of gBGC. This
interval has nine human-specific W→S substitutions over 80 nucleotides, four of which fall within the
exon. Positions in other species that match the human sequence are indicated with a period.
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Supplementary Methods
Clustering, recombination rate, and distance to telomeres
To investigate the degree to which the predicted gBGC tracts are clustered, we calculated for each gBGC
tract the distance to the nearest other gBGC tract (distance-to-nearest). One potential caveat with this type
of analysis is that gBGC tracts were annotated by thresholding posterior probabilities in our HMM (see
Methods), which might cause predictions to occur very close together simply because of fluctuations in
posterior probability along the genome. Therefore, for these analyses, we merged gBGC tracts with their
neighbors if the distance between them was less than 1 kb (the expected gBGC tract length).
gBGC tracts are close in human and chimp. To assess the closeness of gBGC-tracts in human and
chimp we repeated the distance-to-nearest calculation for 1,000 random GC-matched control sets (in human
and chimp separately), and then contrasted the distribution we observed in these controls with the distri-
bution in the gBGC-tracts. Supplementary Figure S4 (panels A and C) summarizes the results in terms
of quantile-quantile plots between the two distributions. This illustrates that gBGC-tracts are significantly
closer together than regions in control sets. For human, the median distance-to-nearest is 24,305 bp, while
the average of median nearest distances across control sets is 86,064.26 bp (with a standard deviation of
1,571.1). For chimp, the median distance-to-nearest in the gBGC tracts is 26,286 bp, and the average me-
dian distance across control sets is 94,882.92 bp (sd = 1,888.2). In both species, we never observe a median
distance-to-nearest in the control sets as low as in the gBGC tracts (z-score based p < 10−100).
gBGC tracts are close to telomeres in human and chimp. To assess distance to telomeres we performed
the same analysis, but used distance to the nearest telomere in place of distance to the nearest neighboring
tract (Supplementary Figure S4, panels B and D). The median distance-to-telomere in human and chim-
panzee are 9,568,725 bp and 8,002,971 bp, while the averages across control sets are 30,393,137 bp (sd =
329,252.1) and 31,209,994 bp (sd = 370,981.5), respectively. In neither species do we observe a median
distance in the control sets that is as low as in the gBGC tracts (p < 10−100).
Distance-to-telomere and recombination rate partially, but not entirely, account for the closeness of
gBGC tracts. Next we asked to what extent distance-to-telomere and recombination rate could be driving
the observed proximity of gBGC tracts to one another. To address this question we fit the following linear
model to the data for each species:
E[X] = a+ β1d+ β2r.
Here, X denotes the logarithm of the distance to the nearest neighboring gBGC tract, d is the log distance-
to-telomere, and r is the mean recombination rate of a tract. We find that, in both species, both β1 and β2
are significantly different from zero (see Supplementary Table S2) and the model predicts gBGC tracts to be
close together near the telomeres and far apart in areas of low recombination rate (also see Supplementary
Figure S12). This is also reflected in Spearman correlation coefficients between distance-to-nearest and
distance-to-telomere (0.36 in human, 0.49 in chimp) and recombination rate (−0.18 in human, −0.20 in
chimp). Despite these significant associations the multiple coefficient of determination (R2) of the linear
model is only about 13% in human and 22% in chimpanzee. That is, the majority of the variance in the
distance-to-nearest observations remains unexplained when taking distance-to-telomere and recombination
rate into account.
Estimation of Fraction of Number of Deleterious Substitutions Due to gBGC
We attempted to estimate the number of deleterious substitutions driven by gBGC by two methods. First,
we compared the bulk distributions of evolutionary conservation scores in regions in eutherian mammals
orthologous to the human tracts and control regions (Supplementary Figure S8). As described in the Meth-
ods section, we used scores computed without the human and chimpanzee sequences to avoid biases from
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human-specific substitutions. Using various methods, we attempted to decompose the bulk distribution of
phyloP scores into a component that could be explained by the distribution observed for control regions and
an excess of evolutionary conservation not explainable based on the control regions (see [36] for a descrip-
tion of similar methods). Second, we devised a method for estimating the expected excess number of human
W→S substitutions in the tracts, relative to the controls. Briefly, this method involved estimating scale fac-
tors for neutral phylogenetic models in the non-human species at positions of human W→S substitutions
in the tracts and controls, and then examining the normalized difference between these factors. However,
we found that both of these methods were highly sensitive to the choice of control regions, as well as to
technical issues such as the choice of threshold for trimming the left-most tail of the CDF in the mixture
decomposition. In the end, we concluded that the patterns of evolutionary conservation were simply too
similar in the tracts and control regions, and too dependent on a complex combination of covariates (GC-
content, recombination rate, exon overlap, etc.), to lead to meaningful estimates of the number of deleterious
substitutions driven by gBGC.
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Figure S1. Additional simulation results. Power and accuracy for gBGC tract prediction as a function of
(A) gBGC strength (Bsim), (B) the tuning parameter B, (C) mean tract coverage, and (D) mean tract length.
Solid lines represent basewise true positive rate (TPR) and dotted lines represent positive predicted value
(PPV). In each plot, tracts were simulated with Bsim = 5, a geometric length distribution with a mean of 1
kb, and mean coverage of 1%, unless otherwise specified by the x-axis. The phylo-HMM was run with the
same parameter settings used for the genome-wide predictions, including B = 3, except in (B) (where B is
varied).
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Figure S2. Length distribution of predicted human gBGC tracts for B = 3.
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Figure S3. W→S bias distribution for human gBGC tracts for B = 3. Histogram of W→S bias, which
is computed for each tract as the fraction of all W→S and S→W substitutions along the human lineage
which are W→S. Human-chimpanzee substitutions were polarized by assuming the allele observed in
orangutan (ponAbe2) was ancestral.
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Figure S4. gBGC tracts are clustered and closer to telomeres than expected by chance. This figure
shows qq-plots contrasting quantiles observed in gBGC tracts (x-axis) with medians of quantiles observed
in GC-matched control sets (points, y-axis). The gray regions correspond to the data range observed across
control regions (with the 1% highest and 1% lowest values removed), while the vertical blue dashed line
denotes the median of the gBGC tracts. Panels A and B show these plots for distance-to-nearest and the
distance-to-telomere in human, C and D show the corresponding plots for chimpanzee.
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Figure S5. Human and chimpanzee gBGC tracts are found in broadly similar locations, but exhibit
fine scale differences. The fraction of bases in gBGC tracts is correlated between human and orthologous
chimpanzee regions (Figure 3). The strength of this correlation increases as larger blocks of the genome are
considered. The gray bars give the average and standard deviation of the correlations observed between the
gBGC fraction in 1000 GC-matched human control regions and the orthologous chimpanzee regions.
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Figure S6. Genomic features significantly enriched or depeleted in gBGC tracts. For each genomic
feature, we compared the number of overlaps observed with gBGC tracts with those observed in 1000
random GC-matched control regions. The gray bars give the minimum and maximum overlaps observed in
the random sets. Shown are all features that are significantly (p < 0.05) underrepresented (blue) or
overrepresented (red) in the tracts. See the Methods for a full list of genomic features considered. Note that
the tracts are more strongly enriched for recombination hotspots (not shown, 1.54x) and for high
recombination rates (Table 3), both of which were considered separately.
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Figure S7. Human polymorphism data indicates an ongoing preference for the fixation of G and C
alleles in the predicted gBGC tracts. This figure shows the same plots as Figure 4, but is based on an
analysis in which polymorphic sites were masked from the alignments. (A) W→S changes in gBGC tracts
have significantly higher derived allele frequencies than S→W changes. This result was obtained on the
YRI population from the 1000 Genomes Project, and patterns for other populations were similar (data not
shown). (B) The U -norm, a measure of the degree of W→S bias (see Methods), is significantly higher in
gBGC tracts than in the entire genome or in GC-matched control regions. Recombination hotspots also
show somewhat elevated values but much less elevated than the predicted tracts. The error bars indicate
95% confidence intervals.
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Figure S8. Conservation at sites of W→S substitutions within tracts. PhyloP scores were calculated at
sites within the predicted human tracts at which W→S substitutions occurred on the human lineage. They
were also calculated at sites of similar human-specific W→S substitution within the GC- and
exon-matched control groups (1000 replicates). The scores were calculated for mammalian alignments
from which the human and chimpanzee sequences had been removed. A higher phyloP score (x-axis)
indicates greater evolutionary conservation. Although there are slight differences between the distributions
for the tracts and the control groups, there is no clear excess of conservation at W→S sites in the tracts.
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Figure S9. Number of chimpanzee polymorphisms in regions orthologous to the gBGC tracts,
compared to controls. We observed significantly more chimpanzee polymorphisms in regions orthologous
to the tracts than those orthologous to the control groups. This is the opposite of the observation that would
be expected if the regions orthologous to the tracts were under purifying selection in the chimpanzee.
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Figure S10. Derived allele frequency spectrum of chimpanzee polymorphisms in regions orthologous
to the tracts. The top plot shows the derived allele frequency spectrum (polarized using the orangutan
allele) for chimpanzee polymorphisms in regions orthologous to the B = 3 gBGC tracts, compared with
the minimum and maximum from 1000 control groups. The bottom plot shows the fraction of samples
from each control group with a higher frequency than observed in the real tracts. We observe no significant
excess of low-frequency derived alleles in regions orthologous to the tracts.
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Enrichment for phastCons elements in W → S positions in tracts
Fr
eq
ue
nc
y
0.55 0.60 0.65 0.70 0.75
0
5
10
15
20
25
30
observed in tracts
Enrichment = 0.703
GC−aware controls 
(mean = 0.590, p < 0.001)
Exon−aware controls
(mean = 0.638, p = 0.031)
Figure S11. W→S sites within the predicted human tracts are enriched for phastCons elements
compared to controls. Enrichments were calculated as the number of W→S sites within tracts falling in
phastCons elements, divided by the number expected if these were distributed independently. The
histograms show enrichment in our sets of 1000 GC- and exon-aware control tracts, and the arrow shows
the value observed in the B = 3 gBGC tracts.
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Figure S12. Distance to telomere and recombination rate correlate with gBGC-tract proximity. This
figure shows box plots of the distribution of the log distance to nearest in the gBGC tract, stratified by log
distance to telomere (first column) and recombination rate (second column) for both human (first row) and
chimp (second row). For both species we observe that gBGC tracts are closer together towards the end of
chromosomes (panels A and C), and that they are further apart in areas of low recombination rate (panels B
and D). These emprical observations agree with the results of our linear modeling analysis (Supplementary
Methods).
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Supplementary Tables
B=2 B=3 B=4 B=5 B=10
B=2 1 0.97 0.95 0.93 0.88
B=3 0.29 1 0.98 0.97 0.92
B=4 0.19 0.64 1 0.99 0.94
B=5 0.13 0.46 0.72 1 0.95
B=10 0.06 0.20 0.31 0.44 1
Table S1. Relative Coverage of Human gBGC Tracts for Various Values of B. Each value in the table
represents the fraction of nucleotides in the human gBGC tract predictions for the value of B indicated for
the row that also fall in the predictions for the value of B indicated for the column. The numbers on the
main diagonal are one by definition. The numbers above the main diagonal indicate the coverage of
smaller sets (higher B) by larger sets (lower B), while the numbers below the main diagonal indicate the
coverage of larger sets by smaller sets.
species coefficient value std. error p-value
human β1 0.431 0.190 < 10−15
human β2 -0.006 0.002 0.006
chimp β1 0.613 0.141 < 10−15
chimp β2 -0.022 0.007 9.8·10−4
Table S2. Distance to telomere and recombination rate are significant factors in predicting
proximity of gBGC tracts. This table shows the coefficients for a linear model in which the log
distance-to-nearest gBGC tract was regressed on the log distance-to-telomere (β1) and recombination rate
(β2). p-values are based on the T -test. The intercept is significant in both species.
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